Tuesday, November 15, 2011 12:38:55 PM
Reason I say this is because:
-- 1) MILV just bought out Nature's Bioceuticals on October 20, 2011 and already acquired 5 herbal formulas; and,
-- 2) MILV stated it plans to go into production and marketing of Sinusitis formula in next 30-60 days.
If company is serious and does what it says, as well as continues to acquire new formulas to create a marketable shelf brand for itself, may set gears in motion toward improved investor confidence and greater PPS, or at least another good trading opportunity.
If not, well, we know where that's going.
5 PRODUCTS:
1. Weight Loss formula
2. Cold + Flu formula
3. Sinusitis formula
4. Kidney tonic
5. [CPOD] Breath Easy formula
POSSIBLY A 6TH:
6. Medical marijuana venture.
_______________________________________________
Mistral Ventures and Cannabis Sciences – Unique Routes to Success, 11/15/11 8:16 AM
http://ih.advfn.com/p.php?pid=nmona&article=49953772
Nature’s Bioceuticals Consummates Purchase of DIABETES formula, 11/15/11, 7:00 AM
http://ih.advfn.com/p.php?pid=nmona&article=49952243&symbol=MILV
11/14/11 -- PennyStockInsiders.com claim CEO, CFO, Directors have not traded the stock in past 3 months.
http://finance.yahoo.com/news/Penny-Stocks-Alerts-Top-prnews-4165454447.html?x=0&l=1
11/11/11 – WEIGHT LOSS formula – finalizes agreement of purchase
http://finance.yahoo.com/news/Nature-Bioceuticals-Finalizes-prnews-560138962.html?x=0&l=1
11/10/11 – COLD + FLU formula – finalizes purchase
http://finance.yahoo.com/news/Nature-Bioceuticals-Finalizes-prnews-2258105606.html?x=0&l=1
11/8/11 – SINUSITIS formula – finalizes purchase; to mfg + ready for sale next 30-60 days
http://finance.yahoo.com/news/Natures-Bioceuticals-prnews-3971130588.html?x=0&.v=1
11/7/11- CHRONIC KIDNEY DISEASE formula – finalizes purchase
http://finance.yahoo.com/news/Natures-Bioceuticals-prnews-4083467528.html?x=0&.v=1
11/3/11 – CPOD formula – to sell as supplement; begins production
http://finance.yahoo.com/news/Natures-Bioceuticals-Decides-prnews-2955016693.html?x=0&.v=1
10/31/11 – Unsolicited Indication of Interest from Foreign Distributor
http://finance.yahoo.com/news/Natures-Bioceuticals-Has-prnews-2506188336.html?x=0&.v=1
10/20/11 – MILV buys 100% interest Nature’s Bioceuticals
http://finance.yahoo.com/news/Mistral-Ventures-Acquires-One-prnews-3650317930.html?x=0&.v=1
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM